Navigation Links
Still River Systems Sign Patent License Agreement With the Massachusetts Institute of Technology
Date:6/22/2011

LITTLETON, Mass., June 22, 2011 /PRNewswire/ -- Still River Systems, Inc. announces today that it has entered into a long-term licensing agreement with the Massachusetts Institute of Technology (M.I.T.) to utilize advanced superconducting accelerator technologies developed at M.I.T.'s Plasma Science and Fusion Center in collaboration with Still River.  Still River will employ those technologies in conjunction with its own leading-edge developments in its groundbreaking single-room proton therapy platform, the Monarch250. This unique medical device houses a revolutionary source of high-energy protons based on the world's highest field strength superconducting synchrocyclotron that provides a significant reduction in the size, cost, and complexity of developing and operating a proton therapy center.

The precision of proton therapy makes it an important treatment option for patients with cancer. Protons can be directed to concentrate their energy precisely on the cancerous tumor while sparing the surrounding healthy tissue, resulting in far fewer short and long-term treatment complications. The first Monarch250 is currently under installation at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, MO, a National Cancer Institute (NCI) Comprehensive Cancer Center.

The proton accelerator has been undergoing complete clinical testing and commissioning, including lifetime testing, and all clinical parameters have exceeded performance expectations. "The innovative design of our proton therapy platform, aided by the technology developed with M.I.T., results in a simple and modular system thus enabling quick, efficient, and cost effective installations," states CEO Joseph Jachinowski. "With our first system nearing completion, we are now beginning to reap the benefits of its unique design by finalizing a complete process that can be replicated to meet the growing proton therapy demand in a cost-efficient manner."

Still River Systems will be exhibiting at the Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Vancouver, British Columbia on July 31st through August 3rd.  

ABOUT STILL RIVER SYSTEMS

Still River Systems, Inc., based in Littleton, Massachusetts, is dedicated to providing physicians, and their patients, access to high quality, cost-effective proton therapy solutions. Still River Systems is developing the Monarch250, an affordable, precise and compact proton therapy system for cancer treatment.

The Monarch250 has not been cleared by the US Food and Drug Administration for distribution or clinical use. For more information on Still River Systems and the Monarch250 Proton Therapy System, please call 978-540-1500 or visit www.stillriversystems.com


'/>"/>
SOURCE Still River Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. National Nasal Allergy Survey Reveals Unmet Needs Still Exist Among Patients Living With Allergic Rhinitis
2. Despite New Changes, Highmark Policy Still Threatens Patients With Primary Immunodeficiency Diseases
3. Report: Inappropriate Antibiotic Use Still High Despite Educational Efforts
4. Video and Stills from Bill & Melinda Gates Foundation Available on thenewsmarket.com: UK Government and Bill & Melinda Gates Foundation Announce New Commitment to Eradicating Polio
5. Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions
6. Still River Systems Announces Production Milestone for the Worlds Smallest High-Energy Proton Therapy Accelerator
7. Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations
8. First Perry Baromedical Sigma Elite Hyperbaric Chamber with EMR Installed at Stillwater Medical Center
9. Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public
10. Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available
11. U.S. Department of Defense Awards $1.2 Million to Study the Use of Vigabatrin to Reduce the Addictive Liability of Opiates While Still Effectively Managing Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... Apple Rehab Shelton Lakes , which specializes in the ... facility as part of a disaster drill on October 3rd. , Apple Rehab participated ... Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid Plan ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... 2017 , ... Leading pediatric oncology experts at Children’s National Health System ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of ...
Breaking Medicine News(10 mins):